1313 results
Map of proliferative blood disorders. 

By Ariella Coler-Reilly @ariellastudies

#Algorithm #classification #proliferative #blood #disorders #leukemia #hematology #oncology
oncology #diagnosis #CML ... #CLL #AML #Map
Normal Hilar Anatomy on Chest X-Ray
The hilum is 95% vessels and while it is not important
branches and the pulmonary ... main bronchus RMB ... lobe bronchus RUL ... intermedius LPA - left Pulmonary
REBEL Review 74: Push-Dose Epinephrine 

9 mL Saline + 1 mL Epi (100mcq/mL) = Epinephrine 10mcg/mL
Epinephrine 9 mL ... Saline + 1 mL Epi ... (100mcq/mL) = Epinephrine ... 10mcg/mL 0.5 ... - 2mL q1-5 min
Endobronchial carcinoid on bronchoscopy

Bronchoscopy in patient with cough/Endobronchial carcinoid- Near complete occlusion RUL bronchus

Dr. Jaykumar Mehta
complete occlusion RUL ... clinical #video #pulmonary
â–º
Magic Mouthwash Ingredients for Mucositis
Magic Mouthwash Recipe 1 (Disp: 480 ml)
 • 80 ml viscous lidocaine
) • 80 ml viscous ... Mylanta • 80 ml ... 12.5 mg per 5 ml ... elixir • 80 ml ... solution • 80 ml
Leukemias Overview: ALL, CML, AML, APML, CLL

Acute leukemias > 20% blasts in the peripheral blood smear
Overview: ALL, CML ... , AML, APML, CLL ... involvement CML ... ↓ LAP Score • CML ... lymphadenopathy CML
Noncardiogenic Pulmonary Edema - Differential Diagnosis Framework

NCPE Pathophysiology:
Noncardiogenic pulmonary edema occurs because of excessive pulmonary capillary
Noncardiogenic Pulmonary ... Noncardiogenic pulmonary ... because of excessive pulmonary ... level <100 pg/ml ... High altitude pulmonary
Causes of Hemoptysis - Differential Diagnosis Algorithm
Massive Hemoptysis (>I00 mL in 24 hours)
 • Malignancy
 •
Hemoptysis (>I00 mL ... Bronchiectasis • Pulmonary ... Fungal Malignancy Pulmonary ... Vascular • Pulmonary ... Algorithm #Causes #Pulmonary
Hyperviscosity Syndrome - Causes and Treatment

 - Waldenstrom macroglobulinemia (most common) / Plasmapheresis 
 - Multiple
transformation (CML ... hyperleukocytosis (AML
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
>10% (or >200 mL ... DLCO >15% (or 3 mL ... systemicsclerosis #SSc #pulmonary